Net Income

E-commerce logistics firm Globavend Holdings raised $1.4M in a direct offering, but its stock tumbled. A look at the deal, the market, and what's next.

RxSight will showcase its unique post-surgery adjustable lens at J.P. Morgan, facing investor questions on growth in a competitive ophthalmology market.

CEO Eric Hambly will face investors at a key conference, balancing oil production strategy with the rising tide of clean technology and decarbonization.

Investors eye Aptiv's upcoming Q4 report for clues on its strategy for EV challenges, software delays, and a looming chip shortage in 2026.

Northann Corp. stock soars on a major retail partnership, but can its innovative 3D printing tech overcome deep financial woes and a delisting threat?

The planned exit of a key technology leader sends ripples through Photronics, raising questions about its innovation roadmap despite record financial success.

Sony Honda Mobility's high-tech AFEELA 1 EV has started trial runs in Ohio, introducing a unique 'Quality Gate' to ensure its advanced tech is flawless.

Entertainment giant Banijay divests its majority stake in bet-at-home to fund a landmark merger with Tipico, reshaping its gaming strategy and the market.

A major study reveals dropping MMR vaccination rates and a surge in measles, but identifies a key window for pediatricians to prevent missed immunizations.

Interactive Brokers reports its clients beat the S&P 500 in 2025. We dive into the numbers, the platform's unique advantages, and what this means for you.

Occidental nets $9.7B from its OxyChem sale to Berkshire Hathaway, pivoting to oil and carbon capture while retaining significant environmental liabilities.

Tesla's Q4 report shows a complex picture. Vehicle deliveries fell short, but record-breaking growth in the energy division hints at a major strategic shift.

Principal Financial is set to unveil its 2026 forecast. Investors weigh strong 2025 results against analyst caution and shifting economic tides.

Known for hair styling, Wavytalk is launching a clinically-tested LED mask. Can this at-home device truly rival professional skincare treatments?

The specialty insurer's acquisition of Apollo is set to add over $1.5B in managed premiums, provide a strategic entry into Lloyd's, and boost tech.

Investors eye Hexcel's Q4 2025 results for signs of an aerospace rebound, strategic shifts under new leadership, and the future of advanced composites.

New ETFs boast yields up to 99%, but a closer look at their complex options strategy reveals significant risks of capital erosion for unwary investors.

Fintech pioneer Currenc Group divests its payments hub Tranglo in a $400M deal, fueling a bold transformation into AI, Web3, and digital assets.

Genelux appoints Dr. Jason Litten as CMO, a strategic move to steer its promising oncolytic virus, Olvi-Vec, through crucial late-stage cancer trials.

Hoth Therapeutics files patents for a therapy to mitigate severe skin reactions from cancer treatments, a strategic move that could transform patient care.